Akebia Therapeutics reported 362.52M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Agios Pharmaceuticals USD 1.18B 4.3B Mar/2026
Akebia Therapeutics 362.52M 357.69M Mar/2026
Alnylam Pharmaceuticals USD 69.29M 60.05M Mar/2026
Amgen USD 657M 4M Mar/2026
Ardelyx USD 5.76M 37K Dec/2025
Astellas Pharma JPY 3.91B 320M Mar/2025
AstraZeneca USD 484M 181M Dec/2025
Bayer EUR 675M 87M Dec/2025
BioMarin Pharmaceutical USD 14.96M 12.18M Mar/2026
Celltrion KRW 19B 1.96B Jun/2025
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
Deva Holding AS TRY 272.53M 69.04M Sep/2023
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Exelixis USD 23.4M 3.9M Sep/2023
Fresenius Medical Care EUR 79M 6M Mar/2026
GlaxoSmithKline GBP 167M 21M Mar/2026
Ionis Pharmaceuticals USD 17M 1000K Mar/2026
Ironwood Pharmaceuticals USD 8.74M 506K Dec/2024
J&J USD 43M 25M Mar/2026
Kangmei Pharma CNY 1.82M 150K Sep/2025
Karyopharm Therapeutics USD 12.62M 1.24M Dec/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Lexicon Pharmaceuticals USD 2.03M 124K Dec/2025
Medical Developments International AUD 18K 3K Jun/2025
Moderna USD 11.49B 36B Mar/2026
Nektar Therapeutics USD 9.77M 3.75M Dec/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Organigram Holdings CAD 179K 127K Mar/2025
Ovoca Bio EUR 7K 6K Jun/2022
Pharma Mar EUR 117K 1.24M Sep/2025
Prothena USD 349.89M 347.27M Mar/2026
PTC Therapeutics USD 2.87B 2.82B Mar/2026
Qiagen NV USD 10.14M 1.92M Dec/2025
Regeneron Pharmaceuticals USD 12.9M 700K Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 178M 203M Mar/2026
Sarepta Therapeutics USD 20.84M 13.28M Dec/2025
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tectonic Therapeutic USD 246.58M 246.56M Mar/2026
Tilray USD 6.7M 2.73M Jun/2025
Vanda Pharmaceuticals -1.37B 1.97B Dec/2025
Zealand Pharma A/S 7.07M 74K Dec/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025